Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy

Journal of the Society for Gynecologic Investigation

Volumn 10, Issue 3, 2003, Pages 161-171

  Chegini, Nasser ^a,b   Verala, Juan ^a   Luo, Xiaoping ^a   Xu, Jingxia ^a   Williams, R Stan ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Gene profiling; Gonadotropin releasing hormone analogue; Leiomyoma; Myometrium

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GONADORELIN DERIVATIVE; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PROTEINASE; RNA; TRANSCRIPTION FACTOR;

ACCURACY; ARTICLE; CANCER HORMONE THERAPY; CELL ACTIVITY; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EXTRACELLULAR MATRIX; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GROWTH REGULATION; HUMAN; HUMAN TISSUE; LEIOMYOMA; MYOMETRIUM; PRIORITY JOURNAL; REPRODUCIBILITY; RNA ISOLATION; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; TISSUE STRUCTURE; UNINDEXED SEQUENCE; UPREGULATION;

CELL CYCLE; CELL DIVISION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEIOMYOMA; MYOMETRIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UTERINE NEOPLASMS;

EID: 0037390966     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(03)00004-2     Document Type: Article

References (55)

1. Brandon D.D., Bethea C.L., Strawn E.Y., et al. Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol. 169:1993;78-85.
2. Brandon D.D., Erickson T.E., Keenan E.J., et al. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab. 80:1995;1876-1881.
3. Fujimoto J., Hirose R., Ichigo S., Sakaguchi H., Li Y., Tamaya T. Expression of progesterone receptor form A and B mRNAs in uterine leiomyoma. Tumour Biol. 19:1998;126-131.
4. Friedman A.J. Treatment of uterine myomas with GnRH agonists. Semin Reprod Endocrinol. 11:1993;154-161.
5. Kettel L.M., Murphy A.A., Morales A.J., Rivier J., Vale W., Yen S.S. Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. Fertil Steril. 60:1993;642-646.
6. Takeuchi H., Kobori H., Kikuchi I., Sato Y., Mitsuhashi N. A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis. J Obstet Gynaecol Res. 26:2000;325-331.
7. Carr B.R., Marshburn P.B., Weatherall P.T., et al. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging A prospective, randomized, double blind, placebo-controlled, crossover trial . J Clin Endocrinol Metab. 76:1993;1217-1223.
8. Chegini N., Rong H., Dou Q., Kipersztok S., Williams R.S. Gonadotropin releasing hormone (GnRH) and GnRH receptor gene expression in human myometrial and leiomyomta and the direct action of GnRH analogs on myometrial smooth muscle cells interaction with ovarian steroids in vitro. J Clin Endocrinol Metab. 81:1996;3215-3221.
9. Chegini N. Implication of growth factor and cytokine networks in leiomyomas. In: Hill J, ed. Cytokines in human reproduction. New Jersey: Wiley, 2000:133-62.
10. Ma C., Chegini N. Matrix metalloproteinases and tissue inhibitor of MMPs (TIMPs) Expression in human myometrial smooth muscle cell and regulation by transforming growth factor β1 . Mol Hum Reprod. 5:1999;950-954.
11. Chegini N., Tang X.M., Ma C. Regulation of transforming growth factor-β1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab. 84:1999;4138-4143.
12. Wu X., Blanck A., Olovsson M., Moller B., Lindblom B. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment. Acta Obstet Gynecol Scand. 80:2001;497-504.
13. Senturk L.M., Sozen I., Gutierrez L., Arici A. Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma. Am J Obstet Gynecol. 184:2001;559-566.
14. Sozen I., Olive D.L., Arici A. Expression and hormonal regulation of monocyte chemotactic protein-1 in myometrium and leiomyomata. Fertil Steril. 69:1998;1095-1102.
15. Kamada Y., Nakatsuka M., Asagiri K., et al. GnRH agonist-suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis. Hum Reprod. 15:2000;2512-2519.
16. Gustavsson I., Englund K., Faxen M., Sjoblom P., Lindblom B., Blanck A. Tissue differences but limited sex steroid responsiveness of c-fos and c-jun in human fibroids and myometrium. Mol Hum Reprod. 6:2000;55-59.
17. Barbarisi A., Petillo O., Di Lieto A., et al. 17-Beta estradiol elicits an autocrine leiomyoma cell proliferation Evidence for a stimulation of protein kinase-dependent pathway . J Cell Physiol. 186:2001;414-424.
18. Mizutani T., Sugihara A., Nakamuro K., Terada N. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate). J Clin Endocrinol Metab. 83:1998;1253-1255.
19. Chegini N, Kornberg L. Gonadotropin releasing hormone analogues (GnRHa) Therapy alters signal transduction pathways involving MAP and focal adhesion kinases in leiomyoma. J Soc Gynecol Invest 2003;10:21-6.
20. Nowak R.A. Fibroids Pathophysiology and current medical treatment . Baillieres Best Pract Res Clin Obstet Gynaecol. 13:1999;223-238.
21. Li X., Gu W., Mohan S., Baylink D.J. DNA microarrays Their use and misuse . Microcirculation. 9:2002;13-22.
22. Skacel M., Skilton B., Pettay J.D., Tubbs R.R. Tissue microarrays A powerful tool for high-throughput analysis of clinical specimens: A review of the method with validation data . Appl Immunohistochem Mol Morphol. 10:2002;1-6.
23. Varela J.C., Goldstein M.H., Baker H.V., Schultz G.S. Microarray analysis of gene expression patterns during healing of rat corneas after excimer laser photorefractive keratectomy. Invest Ophthalmol Vis Sci. 43:2002;1772-1782.
24. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 95:1998;14863-14868.
25. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 98:2001;10515.
26. Dou Q., Tarnuzzer R.W., Williams R.S., Schultz G.S., Chegini N. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata A mechanism for gonadotrophin releasing hormone agonist-induced tumour regression . Mol Hum Reprod. 3:1997;1005-1014.
27. Arici A., Sozen I. Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril. 73:2000;1006-1011.
28. Lee B.S., Nowak R.A. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF β3) and altered responses to the antiproliferative effects of TGF β J Clin Endocrinol Metab. 86:2001;913-920.
29. Li S., Chiang T.C., Davis G.R., Williams R.M., Wilson V.P., McLachlan J.A. Decreased expression of Wnt7a mRNA is inversely associated with the expression of estrogen receptor-alpha in human uterine leiomyoma. J Clin Endocrinol Metab. 86:2001;454-457.
30. Fukuhara K., Kariya M., Kita M., et al. Secreted frizzled related protein 1 is overexpressed in uterine leiomyomas, associated with a high estrogenic environment and unrelated to proliferative activity. J Clin Endocrinol Metab. 87:2002;1729-1736.
31. Kovacs K.A., Oszter A., Gocze P.M., Kornyei J.L., Szabo I. Comparative analysis of cyclin D1 and oestrogen receptor (alpha and beta) levels in human leiomyoma and adjacent myometrium. Mol Hum Reprod. 7:2001;1085-1091.
32. Horiuchi A., Nikaido T., Ya-Li Z., Ito K., Orii A., Fujii S. Heparin inhibits proliferation of myometrial and leiomyomal smooth muscle cells through the induction of alpha-smooth muscle actin, calponin h1 and p27. Mol Hum Reprod. 5:1999;139-145.
33. Noguchi T., Dobashi Y., Minehara H., Itoman M., Kameya T. Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors. Am J Pathol. 156:2000;2135-2147.
34. Andersen J., Grine E., Eng C.L., et al. Expression of connexin-43 in human myometrium and leiomyoma. Am J Obstet Gynecol. 169:1993;1266-1276.
35. Lessl M., Klotzbuecher M., Schoen S., Reles A., Stockemann K., Fuhrmann U. Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium. J Clin Endocrinol Metab. 82:1997;2596-2600.
36. Kupittayanant S., Burdyga T., Wray S. The effects of inhibiting Rho-associated kinase with Y-27632 on force and intracellular calcium in human myometrium. Pflugers Arch. 443:2001;112-114.
37. Tsibris J.C.M., Segars J., Coppola D., et al. Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril. 78:2002;114-121.
38. Rauk P.N., Surti U., Roberts J.M., Michalopoulos G. Mitogenic effect of basic fibroblast growth factor and estradiol on cultured human myometrial and leiomyoma cells. J Obstet Gynecol. 173:1995;571-577.
39. Dou Q., Zhao Y., Tarnuzzer R.W., et al. Suppression of TGF-βs and TGF-β receptors mRNA and protein expression in leiomyomata in women receiving gonadotropin releasing hormone agonist therapy. J Clin Endocrinol Metab. 81:1996;3222-3230.
40. Branton M.H., Kopp J.B. TGF-beta and fibrosis. Microbes Infect. 1:1999;1349-1365.
41. Cheng K.W., Leung P.C. The expression, regulation and signal transduction pathways of the mammalian gonadotropin-releasing hormone receptor. Can J Physiol Pharmacol. 78:2000;1029-1052.
42. Kraus S., Naor Z., Seger R. Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor. Arch Med Res. 32:2001;499-509.
43. Pearson G., Robinson F., Gibson T.B. Mitogen-activated protein (MAP) kinase pathways Regulation and physiological functions . Endocr Rev. 22:2001;153-183.
44. Marais R., Wynne J., Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell. 73:1993;381.
45. Wu X., Blanck A., Olovsson M., Henriksen R., Lindblom B. Expression of Bcl-2, Bcl-x, Mcl-1, Bax and Bak in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause. J Steroid Biochem Mol Biol. 80:2002;77-83.
46. Miller J.R. The Wnts. Genome Biol. 3:2002;1.
47. Saitoh T., Mine T., Katoh M. Frequent up-regulation of WNT5A mRNA in primary gastric cancer. Int J Mol Med. 9:2002;515-519.
48. van Gijn M.E., Snel F., Cleutjens J.P., Smits J.F., Blankesteijn W.M. Overexpression of components of the Frizzled-Dishevelled cascade results in apoptotic cell death, mediated by β-catenin. Exp Cell Res. 265:2001;46-53.
49. Li L., Yuan H., Xie W., et al. Dishevelled proteins lead to two signaling pathways. Regulation of LEF-1 and c-Jun N-terminal kinase in mammalian cells. J Biol Chem. 274:1999;129-134.
50. Grundker C., Volker P., Emons G. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein α(I)-mediated activation of phosphotyrosine phosphatase. Endocrinology. 142:2001;2369-2380.
51. Everest H.M., Hislop J.N., Harding T., et al. Signaling and antiproliferative effects mediated by GnRH receptors after expression in breast cancer cells using recombinant adenovirus. Endocrinology. 142:2001;4663-4672.
52. Stewart E.A., Rhoades A.R., Nowak R.A. Leuprolide acetate-treated leiomyomas retain their relative overexpression of collagen type I and collagen type III messenger ribonucleic acid. J Soc Gynecol Investig. 5:1998;44-47.
53. Palmer S.S., Haynes-Johnson D., Diehl T., Nowak R.A. Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium. J Soc Gynecol Investig. 5:1998;203-209.
54. Fransson L.A., Belting M., Jonsson M., Mani K., Moses J., Oldberg A. Biosynthesis of decorin and glypican. Matrix Biol. 19:2000;367-376.
55. Kresse H., Schonherr E. Proteoglycans of the extracellular matrix and growth control. J Cell Physiol. 189:2001;266-274.